GRENKE AG NA O.N./ DE000A161N30 /
2024-04-24 10:00:59 AM | Chg. -0.10 | Volume | Bid10:20:13 AM | Ask10:20:13 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.40EUR | -0.44% | 2,350 Turnover: 52,790.50 |
22.35Bid Size: 150 | 22.40Ask Size: 230 | 1.04 bill.EUR | 2.10% | 12.49 |
GlobeNewswire
10:05 AM
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American S...
GlobeNewswire
10:00 AM
Perceptyx Launches Activate, HR’s Missing Link Between Employee Insight and Impact
GlobeNewswire
10:00 AM
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00 AM
HRT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that HireRight Holdings Corporation ...
GlobeNewswire
10:00 AM
SSRM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SSR Mining Inc. Investors with...
GlobeNewswire
10:00 AM
NEXT BRIDGE HYDROCARBONS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Next Bridg...
GlobeNewswire
10:00 AM
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire
9:58 AM
New Induction Heating System Revolutionizes Metal Processing with Enhanced Efficiency and Stress Rel...
GlobeNewswire
9:05 AM
CallTower's Seanna Baumgartner Recognized as an Icon's Edge Top 10 Inspiring Leaders of 2024
GlobeNewswire
9:00 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology
GlobeNewswire
9:00 AM
Tower Semiconductor Announces First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
9:00 AM
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board ...